AARON SCHEIB: Open Payments
NPI 1689918666 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,063 in 213 payments from 20 companies in 2025. Trend: 2023 $122 · 2024 $75 · 2025 $4,063
Food & beverage: $4,063
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $613 |
| Otsuka America Pharmaceutical, Inc. | 20 | $483 |
| Alkermes, Inc. | 17 | $435 |
| Teva Pharmaceuticals USA, Inc. | 19 | $418 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $404 |
| Neurocrine BioSciences, Inc. | 12 | $297 |
| Janssen Pharmaceuticals, Inc | 15 | $276 |
| Vanda Pharmaceuticals Inc. | 18 | $196 |
| Corium, LLC | 14 | $196 |
| Axsome Therapeutics, Inc. | 14 | $183 |
Products named: VRAYLAR, CAPLYTA, REXULTI, ARISTADA, INGREZZA, AUSTEDO XR, UZEDY, INVEGA SUSTENNA.
Industry payments across NC — which companies pay providers there.
